Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L2 Ventures
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
L2 Ventures is a private investment firm based in New York that focuses primarily on growth-stage investing in the cannabis sector rather than operating as a drug-development biotechnology or healthcare company. Public profiles describe it as an active venture capital and asset management business with investments across cannabis-related software, marketplace, and consumer companies. Its known portfolio includes companies such as LeafLink, Vangst, Jane Technologies, Grassdoor, and Stillwater Brands. Based on the available evidence, L2 Ventures does not appear to run an internal therapeutic pipeline, develop drug candidates, or market life sciences products or services.
- Industry
- Investors
Beyond the preview
Go deeper on L2 Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L2 Ventures.